Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CRON OTCMKTS:STDAF NYSE:USNA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCRONCronos Group$2.53-0.1%$2.31$1.60▼$2.77$970.63M1.121.91 million shs168,989 shsSTDAFSTADA Arzneimittel Aktiengesellschaft$110.42$110.42$75.15▼$115.00$6.88B0.38180 shsN/AUSNAUSANA Health Sciences$30.16-1.2%$31.09$23.10▼$41.83$551.48M0.64171,169 shs1,410 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCRONCronos Group0.00%+1.20%+6.75%+31.09%+16.06%STDAFSTADA Arzneimittel Aktiengesellschaft0.00%0.00%0.00%0.00%0.00%USNAUSANA Health Sciences0.00%-3.83%+0.56%-0.85%-20.46%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCRONCronos Group$2.53-0.1%$2.31$1.60▼$2.77$970.63M1.121.91 million shs168,989 shsSTDAFSTADA Arzneimittel Aktiengesellschaft$110.42$110.42$75.15▼$115.00$6.88B0.38180 shsN/AUSNAUSANA Health Sciences$30.16-1.2%$31.09$23.10▼$41.83$551.48M0.64171,169 shs1,410 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCRONCronos Group0.00%+1.20%+6.75%+31.09%+16.06%STDAFSTADA Arzneimittel Aktiengesellschaft0.00%0.00%0.00%0.00%0.00%USNAUSANA Health Sciences0.00%-3.83%+0.56%-0.85%-20.46%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCRONCronos Group 0.00N/AN/AN/ASTDAFSTADA Arzneimittel Aktiengesellschaft 0.00N/AN/AN/AUSNAUSANA Health Sciences 2.00Hold$36.0019.38% UpsideCurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCRONCronos Group$117.61M8.23N/AN/A$2.90 per share0.87STDAFSTADA Arzneimittel Aktiengesellschaft$3.84B1.79$11.12 per share9.93$23.11 per share4.78USNAUSANA Health Sciences$854.50M0.64$3.73 per share8.08$27.92 per share1.08Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCRONCronos Group$41.08M$0.0550.7084.27N/A14.19%-3.78%-3.62%11/11/2025 (Estimated)STDAFSTADA Arzneimittel Aktiengesellschaft$292.15MN/A0.00∞N/AN/AN/AN/AN/AUSNAUSANA Health Sciences$42.03M$1.8016.7710.430.973.79%9.48%6.95%10/28/2025 (Estimated)Latest STDAF, CRON, and USNA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/7/2025Q2 2025CRONCronos Group-$0.02-$0.10-$0.08-$0.10$45.73 million$33.46 million7/22/2025Q2 2025USNAUSANA Health Sciences$0.54$0.74+$0.20$0.52$225.20 million$235.85 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCRONCronos GroupN/AN/AN/AN/AN/ASTDAFSTADA Arzneimittel AktiengesellschaftN/AN/AN/AN/AN/AUSNAUSANA Health SciencesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCRONCronos GroupN/A24.6523.53STDAFSTADA Arzneimittel Aktiengesellschaft2.231.540.99USNAUSANA Health SciencesN/A2.151.47Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCRONCronos Group8.71%STDAFSTADA Arzneimittel AktiengesellschaftN/AUSNAUSANA Health Sciences54.25%Insider OwnershipCompanyInsider OwnershipCRONCronos Group6.90%STDAFSTADA Arzneimittel AktiengesellschaftN/AUSNAUSANA Health Sciences0.63%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCRONCronos Group450382.89 million356.47 millionOptionableSTDAFSTADA Arzneimittel Aktiengesellschaft12,50062.34 millionN/ANot OptionableUSNAUSANA Health Sciences1,70018.27 million18.16 millionOptionableSTDAF, CRON, and USNA HeadlinesRecent News About These CompaniesUSANA Launches Next-Generation Celavive Skincare: Advanced Formulas, Expert Ambassadors, Proven ResultsSeptember 11, 2025 | prnewswire.comUSANA Health Sciences, Inc. $USNA Shares Acquired by Jacobs Levy Equity Management Inc.September 11, 2025 | marketbeat.comPetrus Trust Company LTA Takes Position in USANA Health Sciences, Inc. $USNASeptember 10, 2025 | marketbeat.com5 Undervalued Stocks That Are Worth Buying in SeptemberSeptember 9, 2025 | zacks.comUSANA Expands Its Nutritionals Line With Powerful New Products and Enhanced FormulasSeptember 9, 2025 | prnewswire.com12,828 Shares in USANA Health Sciences, Inc. $USNA Bought by Walleye Capital LLCSeptember 6, 2025 | marketbeat.comMagnetar Financial LLC Purchases New Holdings in USANA Health Sciences, Inc. $USNASeptember 4, 2025 | marketbeat.comNuveen LLC Makes New Investment in USANA Health Sciences, Inc. $USNASeptember 4, 2025 | marketbeat.comKevin Guest Encourages Self-Improvement as Path to Harmony, FulfillmentSeptember 2, 2025 | prnewswire.comCharles Schwab Investment Management Inc. Increases Stock Position in USANA Health Sciences, Inc. $USNAAugust 31, 2025 | marketbeat.comAmerican Century Companies Inc. Has $6.88 Million Stock Position in USANA Health Sciences, Inc. $USNAAugust 30, 2025 | marketbeat.comVanguard Group Inc. Cuts Stock Holdings in USANA Health Sciences, Inc. $USNAAugust 29, 2025 | marketbeat.comUSNA or STVN: Which Is the Better Value Stock Right Now?August 28, 2025 | zacks.comVersor Investments LP Buys New Stake in USANA Health Sciences, Inc. $USNAAugust 24, 2025 | marketbeat.comUSANA Introduces New and Upgraded Products, Along with Its Health Professional Advisory CouncilAugust 22, 2025 | prnewswire.com4 Value Stocks Every Investor Should Hold in Volatile TimesAugust 21, 2025 | zacks.comShould Value Investors Buy USANA Health Sciences (USNA) Stock?August 21, 2025 | zacks.comValue Investing: 5 Undervalued Stocks Worth Adding to Your PortfolioAugust 21, 2025 | zacks.com32,269 Shares in USANA Health Sciences, Inc. $USNA Bought by Connor Clark & Lunn Investment Management Ltd.August 19, 2025 | marketbeat.comUSNA vs. STVN: Which Stock Is the Better Value Option?August 12, 2025 | zacks.comUSANA Health Sciences, Inc. (NYSE:USNA) Director Gilbert A. Fuller Sells 1,058 SharesAugust 9, 2025 | insidertrades.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesBuffett Makes Big Moves Outside of UNH: A Buy and Sell BreakdownBy Leo Miller | August 18, 20253 Robotics Stocks at the Heart of the Robotics RevolutionBy Chris Markoch | August 21, 2025NIO Just Got Its Second Upgrade of the Month, and It’s BigBy Sam Quirke | August 28, 2025Micron Stock Still Cheap Despite 25% Rally, Analysts SayBy Gabriel Osorio-Mazilli | August 19, 2025Why Micron Stock Could Outperform NVIDIA in 2025By Gabriel Osorio-Mazilli | September 12, 2025STDAF, CRON, and USNA Company DescriptionsCronos Group NASDAQ:CRON$2.53 0.00 (-0.08%) As of 10:04 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.STADA Arzneimittel Aktiengesellschaft OTCMKTS:STDAF$110.42 0.00 (0.00%) As of 10/24/2022STADA is a publicly traded, international company with a focus on the healthcare market, especially the pharmaceutical and in particular the generics market.USANA Health Sciences NYSE:USNA$30.16 -0.36 (-1.16%) As of 10:04 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 09/08 - 09/12 Wall Street Eyes +30% Upside in Synopsys After Huge Earnings Fall Meta's $600B U.S. Investment: Bearish or Bullish for Shares? Football Season Is Here and DraftKings Stock Is Surging RH Stock Slides After Mixed Earnings and Tariff Concerns Post Onum Deal: Is CrowdStrike Ready to Rebound After 16% Drop? Chewy’s September Pullback: Is It Your Time to Buy? It’s Time to Buy the Dip in Kroger Stock Price Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
